查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611415

皮膚癌皮膚科市場：按檢查、年齡層、設施類型 - 2025-2030 年全球預測

Skin Cancer Dermatology Market by Test (Dermatoscopy, Diagnostic Imaging, Lymph Node Biopsy), Age Group (0-19, 20-39, 40-59), Facility Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年皮膚癌皮膚科市場價值為77.8億美元，預計到2024年將達到84.2億美元，複合年成長率為7.40%，到2030年將達到128.3億美元。

皮膚癌皮膚科市場的範圍涵蓋預防、診斷和治療技術，包括手術、局部和全身治療。由於人口老化、紫外線照射增加和臭氧層消耗，全球皮膚癌發生率不斷增加，因此這個市場至關重要。市場應用多種多樣，包括製藥、生物技術、醫院、皮膚科診所和研究機構。最終用途範圍從患者診斷到量身定做的治療性介入。主要成長動力包括人工智慧診斷等技術進步、醫療保健意識的提高以及政府對早期檢測的支持。此外，創新的局部和免疫療法的商業化提供了潛在的機會，特別是在個人化醫療領域。為了抓住這些機會，公司應該投資數位皮膚健康監測工具和人工智慧主導的診斷平台。然而，高昂的治療成本、監管障礙和保險報銷的複雜性等限制因素對市場成長構成了挑戰。在發展中地區，意識低落和醫療基礎設施有限是額外的障礙。創新成長領域包括非侵入性診斷技術，例如光同調斷層掃瞄和新型光保護劑的開發。標靶治療的遺傳和分子生物學研究和開發也可能推動市場開拓。對遠距皮膚病學和家庭皮膚癌篩檢工具的見解凸顯了市場向偏遠地區個人化患者照護的轉變。市場競爭激烈，主要企業在積極進行併購以增強其產品組合。由於醫療保健領域的研發投資和數位轉型的增加，該市場具有強勁的成長潛力，但企業需要駕馭這一格局，並在充滿挑戰但充滿活力的市場中做好定位，我們需要解決當前的限制並關注監管環境。

主要市場統計
基準年[2023] 77.8億美元
預計年份 [2024] 84.2億美元
預測年份 [2030] 128.3億美元
複合年成長率（%） 7.40%

市場動態：快速發展的皮膚癌皮膚病學市場的關鍵市場洞察

供需的動態交互作用正在改變皮膚癌皮膚科市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球皮膚癌發生率增加
    • 先進醫療基礎設施的可用性
    • 人們對皮膚癌的認知不斷增強
  • 市場限制因素
    • 治療費用上漲
  • 市場機會
    • 隨著遠距皮膚病學的引入不斷發展
    • 智慧型手機相容診斷設備的增加
  • 市場挑戰
    • 嚴格的核准和處理法律規範

波特五力：駕馭皮膚癌皮膚科市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解皮膚癌皮膚科市場的外部影響

外部宏觀環境因素在塑造皮膚癌皮膚病學市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解皮膚癌皮膚科市場的競爭狀況

皮膚癌皮膚病學市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣皮膚癌皮膚科市場供應商的績效評估

FPNV 定位矩陣是評估皮膚癌皮膚科市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了皮膚癌皮膚科市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對皮膚癌皮膚科市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球皮膚癌發生率上升
      • 先進醫療基礎設施的可用性
      • 大眾對皮膚癌的認知提高
    • 抑制因素
      • 資本集中治療和療法
    • 機會
      • 透過引入遠距皮膚病學持續發展
      • 智慧型手機相容診斷設備的增加
    • 任務
      • 嚴格的核准和處理法規結構
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章皮膚癌皮膚科市場測試

  • 皮膚鏡檢查
  • 診斷影像
  • 淋巴結活體組織切片
  • 皮膚切片檢查

第7章皮膚癌皮膚科市場：依年齡層

  • 0-19
  • 20-39
  • 40-59
  • 60-64
  • 65-74
  • 75-84
  • 85歲以上

第8章按設施類型分類的皮膚癌皮膚科市場

  • 皮膚科組
  • 醫院門診
  • 多學科診所
  • 獨立實踐

第9章北美和南美皮膚癌皮膚科市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太皮膚癌皮膚科市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲皮膚癌皮膚科市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Amgen, Inc.
  • Bristol-Myers Squibb Company
  • Canfield Scientific, Inc.
  • Colleyville Dermatology
  • Cutera, Inc.
  • FotoFinder Systems, Inc.
  • Merck & Co., Inc.
  • MetaOptima Technology Inc.
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi SA
  • Skin Analytics Pty Ltd.
  • Speclipse, Inc.
  • Sun Pharmaceutical Industries Limited
Product Code: MRR-0360AB17E0FA

The Skin Cancer Dermatology Market was valued at USD 7.78 billion in 2023, expected to reach USD 8.42 billion in 2024, and is projected to grow at a CAGR of 7.40%, to USD 12.83 billion by 2030.

The scope of the skin cancer dermatology market encompasses prevention, diagnosis, and treatment technologies, including surgical, topical, and systemic therapies. It is essential due to the rising incidence of skin cancer globally, driven by aging populations, increased UV exposure, and ozone layer depletion. The market applications range across pharmaceutical and biotechnological sectors, hospitals, dermatology clinics, and research institutions. End-use scope extends from patient diagnostics to tailored therapeutic interventions. Key growth drivers include technological advancements like AI in diagnostics, increased healthcare awareness, and supportive government initiatives for early detection. Furthermore, the commercialization of innovative topical therapies and immunotherapies presents potential opportunities, particularly in the personalized medicine domain. To seize these opportunities, companies should invest in digital skin health monitoring tools and AI-driven diagnostic platforms. However, limitations such as high treatment costs, regulatory hurdles, and the complexity of insurance reimbursements challenge market growth. In developing regions, the lack of awareness and limited healthcare infrastructure pose additional barriers. Innovative areas for growth include non-invasive diagnostic technologies, such as optical coherence tomography, and the development of novel photoprotective agents. Exploring genetic and molecular research for targeted therapies could also propel market developments. Insights into teledermatology and home-based skin cancer screening tools highlight the market's shift towards remote and personalized patient care. The nature of the market is highly competitive, with key players actively engaging in mergers and acquisitions to enhance their portfolios. While the market offers robust growth potential due to increased R&D investments and healthcare's digital transformation, companies must address current limitations and focus on regulatory compliance to successfully navigate this landscape and position themselves advantageously in a market that is as dynamic as it is challenging.

KEY MARKET STATISTICS
Base Year [2023] USD 7.78 billion
Estimated Year [2024] USD 8.42 billion
Forecast Year [2030] USD 12.83 billion
CAGR (%) 7.40%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Skin Cancer Dermatology Market

The Skin Cancer Dermatology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidences of skin cancer worldwide
    • Availability of advanced healthcare infrastructure
    • Rising awareness about skin cancer among the population
  • Market Restraints
    • Capital intensive treatment with therapy
  • Market Opportunities
    • Ongoing development with introduction of teledermatology
    • Increasing number of smartphone-compatible diagnostic devices
  • Market Challenges
    • Strict regulatory framework for the approval and treatment

Porter's Five Forces: A Strategic Tool for Navigating the Skin Cancer Dermatology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Skin Cancer Dermatology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Skin Cancer Dermatology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Skin Cancer Dermatology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Skin Cancer Dermatology Market

A detailed market share analysis in the Skin Cancer Dermatology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Skin Cancer Dermatology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Skin Cancer Dermatology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Skin Cancer Dermatology Market

A strategic analysis of the Skin Cancer Dermatology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Skin Cancer Dermatology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen, Inc., Bristol-Myers Squibb Company, Canfield Scientific, Inc., Colleyville Dermatology, Cutera, Inc., FotoFinder Systems, Inc., Merck & Co., Inc., MetaOptima Technology Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sanofi S.A., Skin Analytics Pty Ltd., Speclipse, Inc., and Sun Pharmaceutical Industries Limited.

Market Segmentation & Coverage

This research report categorizes the Skin Cancer Dermatology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Test, market is studied across Dermatoscopy, Diagnostic Imaging, Lymph Node Biopsy, and Skin Biopsy.
  • Based on Age Group, market is studied across 0-19, 20-39, 40-59, 60-64, 65-74, 75-84, and 85 & Above.
  • Based on Facility Type, market is studied across Dermatology Group, Hospital OPD, Multispecialty Clinics, and Stand Alone Practices.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of skin cancer worldwide
      • 5.1.1.2. Availability of advanced healthcare infrastructure
      • 5.1.1.3. Rising awareness about skin cancer among the population
    • 5.1.2. Restraints
      • 5.1.2.1. Capital intensive treatment with therapy
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing development with introduction of teledermatology
      • 5.1.3.2. Increasing number of smartphone-compatible diagnostic devices
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory framework for the approval and treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Skin Cancer Dermatology Market, by Test

  • 6.1. Introduction
  • 6.2. Dermatoscopy
  • 6.3. Diagnostic Imaging
  • 6.4. Lymph Node Biopsy
  • 6.5. Skin Biopsy

7. Skin Cancer Dermatology Market, by Age Group

  • 7.1. Introduction
  • 7.2. 0-19
  • 7.3. 20-39
  • 7.4. 40-59
  • 7.5. 60-64
  • 7.6. 65-74
  • 7.7. 75-84
  • 7.8. 85 & Above

8. Skin Cancer Dermatology Market, by Facility Type

  • 8.1. Introduction
  • 8.2. Dermatology Group
  • 8.3. Hospital OPD
  • 8.4. Multispecialty Clinics
  • 8.5. Stand Alone Practices

9. Americas Skin Cancer Dermatology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Skin Cancer Dermatology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Skin Cancer Dermatology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Amgen, Inc.
  • 3. Bristol-Myers Squibb Company
  • 4. Canfield Scientific, Inc.
  • 5. Colleyville Dermatology
  • 6. Cutera, Inc.
  • 7. FotoFinder Systems, Inc.
  • 8. Merck & Co., Inc.
  • 9. MetaOptima Technology Inc.
  • 10. Novartis AG
  • 11. Pfizer Inc.
  • 12. Regeneron Pharmaceuticals, Inc.
  • 13. Sanofi S.A.
  • 14. Skin Analytics Pty Ltd.
  • 15. Speclipse, Inc.
  • 16. Sun Pharmaceutical Industries Limited

LIST OF FIGURES

  • FIGURE 1. SKIN CANCER DERMATOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. SKIN CANCER DERMATOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SKIN CANCER DERMATOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SKIN CANCER DERMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SKIN CANCER DERMATOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SKIN CANCER DERMATOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DERMATOSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY LYMPH NODE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY SKIN BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY 0-19, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY 20-39, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY 40-59, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY 60-64, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY 65-74, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY 75-84, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY 85 & ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DERMATOLOGY GROUP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY HOSPITAL OPD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY MULTISPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY STAND ALONE PRACTICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. SKIN CANCER DERMATOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 153. SKIN CANCER DERMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2023